QVance AB Announces Nordic Partnership with bioMérieux
QVance AB, Huddinge, Sweden has today announced it has entered into a partnership with bioMérieux Sweden AB, aimed at enhancing the quality analytics offerings in microbiology and mycoplasma testing for cell and gene therapy product development and releasebioMérieux, a world leader in the field of in vitro diagnostics, pioneer, develop and produce high quality diagnostic solutions to improve public health worldwide. This collaboration will leverage the strengths of both companies to offer innovative solutions and support the advanced therapy community in the Nordics. QVance, in addition to